Professor
National Institute of Pharmaceutical and Educational Research, India
Prof. Sanyog Jain is currently working on the development of custom-made nanotech-driven formulations, using biodegradable lipids and polymers for delivering various difficult-to-deliver drugs and macromolecules such as proteins, vaccines, and RNAi therapeutics. He has successfully utilized technologies like phospholipid complexes, lipid-drug conjugates, prodrug approaches, micelles, and protein/polymer-based delivery systems for tumor-targeted delivery. Further, he has developed technologies for oral vaccine delivery, oral insulin delivery and improving oral bioavailability of several other therapeutic agents. Furthermore, he is well-versed in topical and transdermal drug delivery systems and has been using them for managing cancer, psoriasis, and acne. He has developed in-house technology which is scalable and industrially adaptable. The transfer of tamoxifen-self emulsifying drug delivery system (for breast cancer) to VAV-Life Sciences in India, confirms his strong industry-academic link. Furthermore, the National Research Development Corporation (NRDC) has shortlisted two of his technologies: Gemcitabine-Phospholipid combination (for enhancing metabolic stability and deliverability) and Betamethasone+Calcipotriol loaded nanoemulgel for psoriasis therapy. Prof. Jain has established an excellent scientific track record with high-impact scientific publications with >215 international publications, 15 patents (12 granted and 3 filed), 2 books and 10 book chapters; with a cumulative impact factor of: 1360.803; h-index: 56 and i10-index: 178. Till now Prof. Jain has supervised 2 postdocs, 16 PhDs, and 118 M.S. students and at present, he is guiding 1 postdoc, 10 PhDs and 10 M.S. students. Stanford University has listed Prof. Jain in the list of the world’s top 2% scientists (in the discipline of pharmacy and pharmacology) in October 2021. Prof. Jain's research has always been focused on national and social issues, and his work has received funding from several government agencies, including the Department of Science and Technology (DST), the Department of Biotechnology (DBT), the Indian Council of Medical Research (ICMR), and the Indian National Science Academy (INSA).